SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaledonia Regulatory News (CLDN)

Share Price Information for Caledonia (CLDN)

Share Price is delayed by 15 minutes
Get Live Data
355.00    -0.50 (-0.14%)
Bid:
351.00
Ask:
356.00
Spread: 5.00 (1.425%)
Market Cap: £1.82b
CLDN Live PriceLast checked at - London Stock Exchange

Intraday Caledonia Share Chart

Director/PDMR Shareholding

25 Mar 2015 13:12

RNS Number : 4494I
Caledonia Investments PLC
25 March 2015
Β 

Caledonia Investments plc

Director/PDMR Shareholding Notification

Β 

Caledonia Investments plc ("Caledonia") has been notified pursuant to DTR 3.1.2R of the following transaction in its ordinary shares of 5p each involving two of its directors, William Wyatt and The Honourable Charles Cayzer, and Mr Wyatt's four minor children, Isabella, Oliver, India and Johnny, being persons connected with him.Β 

Β 

On 23 March 2015, a family trust of which Mr Wyatt's children are beneficiaries purchased 2,000 shares in Caledonia at a price of 2333p per share from a close family relative. The purchase was conducted off-market and in London. Both Mr Wyatt and The Hon Charles Cayzer are trustees of this trust and therefore Caledonia shares held by it are included respectively in their beneficial and non-beneficial interests. The shares purchased by the trust will be registered in the name of Caytrust Finance Company Limited.

Β 

Mr Wyatt's total interests in Caledonia's ordinary shares following the above transaction are as follows:

Β 

Beneficial - 1,060,365* shares = 1.91%

Non-beneficial - 28,293 shares = 0.05%

Options - 19,496 shares = 0.04%

Performance share scheme awards - 109,202 = 0.20%

Deferred bonus plan awards - 49,224 shares = 0.09%

Β 

* includes 953,066 shares owned by The Dunchurch Lodge Stud Company, a private company controlled by Mr Wyatt and persons connected with him.

Β 

The Honourable Charles Cayzer's total interests in Caledonia's ordinary shares following the above transaction are as follows:

Β 

Beneficial - 40,092 shares = 0.07%

Non-beneficial - 21,500 shares = 0.04%

Β 

Β 

Name of duly authorised officer of issuer responsible for making notification:

Β 

K M Burwood

Deputy Company Secretary

Tel: +44 20 7802 8080

Β 

25 March 2015

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
RDSSEFFDIFISEFD
Date   Source Headline
5th Jul 20247:00 amRNSTransaction in Own Shares
4th Jul 202411:29 amRNSNet Asset Value(s)
1st Jul 20247:00 amRNSTotal Voting Rights
1st Jul 20247:00 amRNSTransaction in Own Shares
24th Jun 20247:00 amRNSTransaction in Own Shares
13th Jun 20244:00 pmRNSAnnual Financial Report
7th Jun 20245:22 pmRNSDirector/PDMR Shareholding
6th Jun 20243:28 pmRNSDirector/PDMR Shareholding
6th Jun 20249:39 amRNSNet Asset Value(s)
30th May 20242:55 pmRNSDirector/PDMR Shareholding
21st May 20247:00 amRNSFinal Results
7th May 202410:40 amRNSNet Asset Value(s)
1st May 20247:00 amRNSTotal Voting Rights
1st May 20247:00 amRNSTransaction in Own Shares
29th Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSNotice of annual results
22nd Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:30 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSUnaudited net asset value and portfolio update
2nd Apr 20247:01 amRNSTotal Voting Rights
2nd Apr 20247:00 amRNSTransaction in Own Shares
28th Mar 20243:19 pmRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 202410:32 amRNSDirector Declaration
6th Mar 20242:33 pmRNSNet Asset Value(s)
20th Feb 20245:02 pmRNSDirector/PDMR Shareholding
7th Feb 20241:31 pmRNSNet Asset Value(s)
30th Jan 20243:58 pmRNSDirector/PDMR Shareholding
19th Jan 20244:30 pmRNS2023 AGM results update statement
18th Jan 202411:56 amRNSDisposal
8th Jan 20247:00 amRNSUnaudited net asset value and portfolio update
7th Dec 20232:19 pmRNSNet Asset Value(s)
29th Nov 202311:49 amRNSDirector/PDMR Shareholding
27th Nov 20234:37 pmRNSDirector/PDMR Shareholding
21st Nov 20237:00 amRNSHalf-year Report
14th Nov 20233:28 pmRNSNotice of Half-Year Results
7th Nov 20237:00 amRNSNet Asset Value(s)
6th Oct 20237:00 amRNSUnaudited net asset value and portfolio update
28th Sep 20233:28 pmRNSDirector/PDMR Shareholding
25th Sep 202310:58 amRNSDirector/PDMR Shareholding
20th Sep 20239:56 amRNSDirector/PDMR Shareholding
8th Sep 20234:34 pmRNSDirector/PDMR Shareholding
7th Sep 20231:50 pmRNSDirector/PDMR Shareholding
5th Sep 20237:00 amRNSCaledonia signs agreement to sell 7IM
7th Aug 20237:00 amRNSNet Asset Value(s)
19th Jul 20235:53 pmRNSResult of AGM
7th Jul 202310:22 amRNSNet Asset Value and Portfolio Update
15th Jun 20234:01 pmRNSAnnual Financial Report
9th Jun 20235:27 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.